IL7R and Erythema: In contrast, none of the three baboons treated with the site-1 anti-IL-7Rα mAb displayed a reduced erythema response, in spite of a similar pharmacokinetic profile of the antibody and a similar occupancy of the receptors (Supplementary Figure 2B–C).